- Home
- AZZ vs XENE Comparison
AZZ vs XENE Comparison
Compare AZZ & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- XENE
- Stock Information
- Founded
- AZZ 1956
- XENE 1996
- Country
- AZZ United States
- XENE Canada
- Employees
- AZZ N/A
- XENE N/A
- Industry
- AZZ Industrial Specialties
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- AZZ Industrials
- XENE Health Care
- Exchange
- AZZ Nasdaq
- XENE Nasdaq
- Market Cap
- AZZ 2.7B
- XENE 2.5B
- IPO Year
- AZZ N/A
- XENE 2014
- Fundamental
- Price
- AZZ $90.75
- XENE $35.54
- Analyst Decision
- AZZ Strong Buy
- XENE Strong Buy
- Analyst Count
- AZZ 8
- XENE 9
- Target Price
- AZZ $100.71
- XENE $56.22
- AVG Volume (30 Days)
- AZZ 247.2K
- XENE 862.0K
- Earning Date
- AZZ 04-21-2025
- XENE 05-12-2025
- Dividend Yield
- AZZ 0.75%
- XENE N/A
- EPS Growth
- AZZ N/A
- XENE N/A
- EPS
- AZZ 1.79
- XENE N/A
- Revenue
- AZZ $1,577,744,000.00
- XENE N/A
- Revenue This Year
- AZZ $7.56
- XENE N/A
- Revenue Next Year
- AZZ $3.06
- XENE $1,553.36
- P/E Ratio
- AZZ $50.71
- XENE N/A
- Revenue Growth
- AZZ 2.61
- XENE N/A
- 52 Week Low
- AZZ $69.59
- XENE $26.74
- 52 Week High
- AZZ $99.49
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- AZZ 61.18
- XENE 49.08
- Support Level
- AZZ $86.88
- XENE $37.46
- Resistance Level
- AZZ $91.34
- XENE $39.01
- Average True Range (ATR)
- AZZ 3.27
- XENE 1.68
- MACD
- AZZ 0.88
- XENE -0.14
- Stochastic Oscillator
- AZZ 93.84
- XENE 48.59
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. In its Metal Coatings segment, the company offers metal finishing services to protect against corrosion, such as hot dip galvanizing, spin galvanizing, powder coating, anodizing, and plating. The Precoat Metals Segment offers aesthetic and corrosion-resistant coatings for steel and aluminum coils.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.